Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AVBPArriVent BioPharma, Inc.

Nasdaq · CIK 0001868279
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts163

Identity from submissions API

NameArriVent BioPharma, Inc.
CIK0001868279
TickersAVBP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone240-780-6356
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
18 CAMPUS BLVD.
SUITE 100
NEWTOWN SQUARE
PA
19073-3269
PA
Mailing address
18 CAMPUS BLVD.
SUITE 100
NEWTOWN SQUARE
PA
19073-3269
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

162 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 10-Q 10-Q 0001104659-26-124513 001-41929 261536277 34 6655375 1 1
2026-11-09 8-K FORM 8-K 2.02,5.02,9.01 0001104659-26-124484 001-41929 261535891 34 306893 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002691 005-94331 261526083 34 11656
2026-11-02 4 OWNERSHIP DOCUMENT 0001104659-26-121410 24162
2026-10-26 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-118550 001-41929 261483366 34 220565 1 1
2026-10-19 8-K FORM 8-K 7.01,9.01 0001104659-26-116736 001-41929 261467559 34 220979 1 1
2026-10-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-109019 005-94331 261456860 34 25442
2026-10-13 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-115161 001-41929 261454290 34 210618 1 1
2026-10-08 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000931 005-94331 261450814 34 33838
2026-10-06 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-113898 001-41929 261442341 34 229550 1 1
2026-08-12 10-Q 10-Q 0001104659-26-094902 001-41929 261267807 34 6056079 1 1
2026-08-12 8-K FORM 8-K 1.01,2.02,9.01 0001104659-26-094869 001-41929 261267499 34 305460 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002185 005-94331 261206121 34 11127
2026-06-22 4 OWNERSHIP DOCUMENT 0001104659-26-076570 5781
2026-06-22 4 OWNERSHIP DOCUMENT 0001104659-26-076569 5839
2026-06-22 4 OWNERSHIP DOCUMENT 0001104659-26-076567 5832
2026-06-22 4 OWNERSHIP DOCUMENT 0001104659-26-076566 5815
2026-06-22 8-K FORM 8-K 5.07 0001104659-26-076352 001-41929 261106928 34 200525 1 1
2026-05-11 8-K FORM 8-K 8.01,9.01 0001104659-26-058706 001-41929 26963973 34 222206 1 1
2026-05-11 424B5 424B5 0001104659-26-058700 333-284661 26963936 33 652535 1 1
2026-05-11 10-Q 10-Q 0001104659-26-058650 001-41929 26963238 34 5420785 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001104659-26-058638 001-41929 26963147 34 336151 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001106 005-94331 26946568 34 11391
2026-04-28 ARS ARS 0001104659-26-050350 001-41929 26907924 34 4673742
2026-04-28 DEFA14A DEFA14A 0001104659-26-050344 001-41929 26907819 34 321591
2026-04-28 DEF 14A FORM- DEF 14A 0001104659-26-050337 001-41929 26907738 34 1871887 1 1
2026-03-17 8-K 8-K 7.01,8.01,9.01 0001104659-26-029588 001-41929 26763228 34 194203 1 1
2026-03-05 S-8 FORM S-8 0001104659-26-024136 333-294056 26726481 33 195276 1 1
2026-03-05 10-K 10-K 0001104659-26-024127 001-41929 26726381 34 13580795 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001104659-26-024112 001-41929 26726227 34 318909 1 1
2026-03-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-023750 005-94331 26724084 34 29253
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002058093-26-000004 005-94331 26642411 34 9468
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001013 005-94331 26636909 34 8958
2026-02-04 4 OWNERSHIP DOCUMENT 0001104659-26-010478 5695
2026-02-04 4 OWNERSHIP DOCUMENT 0001104659-26-010477 5686
2026-02-04 4 OWNERSHIP DOCUMENT 0001104659-26-010473 5701
2026-02-04 4 OWNERSHIP DOCUMENT 0001104659-26-010472 5650
2026-02-04 4 OWNERSHIP DOCUMENT 0001104659-26-010471 5671
2026-02-03 4 xslF345X05/ownership.xml 0000902664-26-000675 9801
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000090 005-94331 26581903 34 7186
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000643 005-94331 26545829 34 10985
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016716 005-94331 251487627 34 14151
2025-11-10 10-Q 10-Q 0001104659-25-108847 001-41929 251464434 34 6141860 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001104659-25-108839 001-41929 251464408 34 361364 1 1
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002677 005-94331 251452567 34 11701
2025-10-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000025 005-94331 251433979 34 6283
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002500 005-94331 251401780 34 11038
2025-10-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-099728 005-94331 251394897 34 7887
2025-09-09 8-K 8-K 7.01,8.01,9.01 0001558370-25-011954 001-41929 251301691 34 200993 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021943 005-94331 251220640 34 7597
2025-08-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000764 005-94331 251213647 34 33755
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004712 005-94331 251213611 34 17209
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002058093-25-000008 005-94331 251213315 34 9906
2025-08-11 10-Q 10-Q 0001558370-25-010975 001-41929 251200250 34 6489197 1 1
2025-08-11 8-K 8-K 2.02,9.01 0001558370-25-010974 001-41929 251200243 34 367122 1 1
2025-07-21 8-K FORM 8-K 8.01,9.01 0001104659-25-069169 001-41929 251135757 34 216348 1 1
2025-07-15 4 OWNERSHIP DOCUMENT 0001104659-25-067928 15780
2025-07-02 424B5 424B5 0001104659-25-065391 333-284661 251102323 33 636707
2025-07-02 8-K FORM 8-K 1.01,8.01,9.01 0001104659-25-065386 001-41929 251102276 34 738275 1 1
2025-07-01 424B5 424B5 0001104659-25-064736 333-284661 251096500 33 607094
2025-06-23 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-061375 001-41929 251062954 34 241188 1 1
2025-06-20 4 OWNERSHIP DOCUMENT 0001104659-25-061270 5357
2025-06-20 4 OWNERSHIP DOCUMENT 0001104659-25-061269 5418
2025-06-20 4 OWNERSHIP DOCUMENT 0001104659-25-061268 5411
2025-06-20 4 OWNERSHIP DOCUMENT 0001104659-25-061267 5394
2025-06-20 8-K FORM 8-K 5.07 0001104659-25-061165 001-41929 251061510 34 198878 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002058093-25-000002 005-94331 25954390 34 9703
2025-05-12 10-Q 10-Q 0001558370-25-007276 001-41929 25932935 34 6076466 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001558370-25-007259 001-41929 25932660 34 339740 1 1
2025-04-29 4 OWNERSHIP DOCUMENT 0001104659-25-041344 5563
2025-04-29 3 OWNERSHIP DOCUMENT 0001104659-25-041340 12313
2025-04-28 ARS ARS 0001104659-25-040239 001-41929 25880855 34 4497531
2025-04-28 DEFA14A DEFA14A 0001104659-25-040227 001-41929 25880671 34 319352
2025-04-28 DEF 14A DEF 14A 0001104659-25-040214 001-41929 25880588 34 1895969 1 1
2025-04-28 8-K FORM 8-K 5.02,7.01,9.01 0001104659-25-039799 001-41929 25876032 34 238849 1 1
2025-03-13 8-K 8-K 4.01,9.01 0001558370-25-002912 001-41929 25736665 34 173707 1 1
2025-03-03 S-8 FORM S-8 0001104659-25-019484 333-285480 25693784 33 94274
2025-03-03 8-K 8-K 2.02,9.01 0001558370-25-002002 001-41929 25693776 34 341139 1 1
2025-03-03 10-K 10-K 0001558370-25-001999 001-41929 25693768 34 13029776 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021707 005-94331 25632195 34 7366
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014175 5657
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014172 5693
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014170 5702
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014164 5708
2025-02-14 4 OWNERSHIP DOCUMENT 0001104659-25-014160 5678
2025-02-03 S-3ASR S-3ASR 0001104659-25-008356 333-284661 25580581 33 1678128
2025-01-22 8-K FORM 8-K 1.01,7.01,9.01 0001104659-25-004967 001-41929 25543611 34 227402 1 1
2024-12-04 SC 13G d11538049_13g.htm 0000919574-24-007004 005-94331 241526622 34 108267
2024-11-14 SC 13G ARRIVENT BIOPHARMA, INC. 0000902664-24-006621 005-94331 241463315 34 60001
2024-11-14 10-Q 10-Q 0001558370-24-015624 001-41929 241457295 34 5606576 1 1
2024-11-14 8-K 8-K 2.02,9.01 0001558370-24-015622 001-41929 241457279 34 319612 1 1
2024-11-12 SC 13G SC 13G 0001104659-24-116708 005-94331 241447136 34 117818
2024-11-12 SC 13G filing.txt 0000315066-24-002662 005-94331 241444451 34 8307
2024-11-08 SC 13G us04272n1028_110824.txt 0002012383-24-003521 005-94331 241439669 34 13776
2024-10-24 SC 13G us04272n1028_102424.txt 0002012383-24-002199 005-94331 241392066 34 13764
2024-10-11 SC 13G avbp1011241sc13g.htm 0001214659-24-017477 005-94331 241367544 34 91215
2024-09-23 4 OWNERSHIP DOCUMENT 0001104659-24-102146 23533
2024-09-09 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-098059 001-41929 241286528 34 237924 1 1
2024-08-14 10-Q 10-Q 0001558370-24-012236 001-41929 241208059 34 5669032 1 1
2024-08-14 8-K 8-K 2.02,9.01 0001558370-24-012223 001-41929 241207468 34 373987 1 1
2024-07-09 8-K/A 8-K/A 5.02 0001104659-24-078587 001-41929 241108038 34 203632 1 1
2024-07-09 8-K/A FORM 8-K/A 5.02,9.01 0001104659-24-078585 001-41929 241108013 34 231668 1 1
2024-06-05 8-K FORM 8-K 1.01,7.01,9.01 0001104659-24-068503 001-41929 241020711 34 228595 1 1
2024-05-20 4 OWNERSHIP DOCUMENT 0001104659-24-063518 5624
2024-05-20 3 OWNERSHIP DOCUMENT 0001104659-24-063516 11871
2024-05-16 8-K FORM 8-K 5.02,9.01 0001104659-24-062528 001-41929 24955661 34 238788 1 1
2024-05-08 10-Q 10-Q 0001558370-24-007197 001-41929 24924309 34 4412821 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001558370-24-007196 001-41929 24924295 34 340799 1 1
2024-04-23 4 OWNERSHIP DOCUMENT 0001104659-24-050577 5626
2024-04-23 3 OWNERSHIP DOCUMENT 0001104659-24-050572 3246
2024-04-22 8-K FORM 8-K 5.02,9.01 0001104659-24-049988 001-41929 24861289 34 226052 1 1
2024-03-28 10-K 10-K 0001558370-24-004280 001-41929 24800339 34 4396641
2024-03-28 8-K FORM 8-K 2.02,9.01 0001104659-24-040532 001-41929 24799119 34 286069 1 1
2024-02-13 SC 13G SCHEDULE 13G 0001213900-24-013438 005-94331 24630068 34 128478
2024-02-05 SC 13D SCHEDULE 13D 0000947871-24-000091 005-94331 24596387 34 182637
2024-02-02 S-8 FORM S-8 0001104659-24-010025 333-276840 24591439 33 121962
2024-02-01 4 xslF345X05/ownership.xml 0000902664-24-000903 18415
2024-01-31 4 OWNERSHIP DOCUMENT 0001104659-24-008799 31078
2024-01-31 4 OWNERSHIP DOCUMENT 0001104659-24-008797 25562
2024-01-31 4 OWNERSHIP DOCUMENT 0001104659-24-008796 10096
2024-01-30 8-K FORM 8-K 5.03,8.01,9.01 0001104659-24-008228 001-41929 24578163 34 418416 1 1
2024-01-29 4 OWNERSHIP DOCUMENT 0001104659-24-007733 5500
2024-01-29 4 OWNERSHIP DOCUMENT 0001104659-24-007732 5465
2024-01-26 SEC STAFF LETTER filename1.pdf 9999999997-24-000221 63823
2024-01-26 424B4 424B4 0001104659-24-007261 333-276397 24567874 33 5681668
2024-01-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-25 17:00:00 9999999995-24-000212 333-276397 24563985 33 1776
2024-01-25 3 xslF345X02/ownership.xml 0000902664-24-000669 8067
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006839 16674
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006838 20519
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006837 13186
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006835 19117
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006834 21496
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006833 13149
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006832 15586
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006831 14041
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006828 19263
2024-01-25 3 OWNERSHIP DOCUMENT 0001104659-24-006827 14542
2024-01-25 S-1MEF S-1MEF 0001104659-24-006807 333-276699 24563670 33 77944
2024-01-25 CERT 8A_cert_AVBP.pdf 0001354457-24-000034 001-41929 24560589 34 154473
2024-01-23 S-1/A S-1/A 0001104659-24-005933 333-276397 24553506 33 5813990
2024-01-23 8-A12B 8-A12B 0001104659-24-005880 001-41929 24552573 34 14567
2024-01-23 CORRESP filename1.htm 0001104659-24-005879 13177
2024-01-23 CORRESP filename1.htm 0001104659-24-005876 9289
2024-01-22 CORRESP filename1.htm 0001104659-24-005370 21022
2024-01-22 S-1/A S-1/A 0001104659-24-005364 333-276397 24547042 33 6342885
2024-01-12 UPLOAD filename1.pdf 0000000000-24-000472 377-06842 44422
2024-01-11 CORRESP filename1.htm 0001104659-24-003272 116488
2024-01-05 S-1 S-1 0001104659-24-001804 333-276397 24516457 33 9161918
2023-12-06 DRS/A filename1.htm 0001104659-23-123723 377-06842 231468242 33 7038914
2023-12-05 DRSLTR filename1.htm 0001104659-23-123726 25813
2023-11-15 UPLOAD filename1.pdf 0000000000-23-012534 377-06842 47864
2023-10-31 DRSLTR filename1.htm 0001104659-23-113011 60311
2023-10-31 DRS/A filename1.htm 0001104659-23-113008 377-06842 231365749 33 7022904
2023-10-18 UPLOAD filename1.pdf 0000000000-23-011405 377-06842 65321
2023-10-13 SEC STAFF LETTER filename1.pdf 9999999997-23-004535 64923
2023-10-04 DRSLTR filename1.htm 0001104659-23-106887 115178
2023-10-04 DRS/A filename1.htm 0001104659-23-106884 377-06842 231308935 33 6353822
2023-09-27 UPLOAD filename1.pdf 0000000000-23-010683 377-06842 80568
2023-08-25 DRS filename1.htm 0001104659-23-095379 377-06842 231209007 33 9779368
2022-12-29 D xslFormDX01/primary_doc.xml 06b 0001868279-22-000002 021-469072 221497473 33 11031
2022-02-14 D/A xslFormDX01/primary_doc.xml 06b 0001868279-22-000001 021-403969 22629931 33 8441
2021-06-23 D xslFormDX01/primary_doc.xml 06b 0001868279-21-000002 021-403969 211038894 33 5927

Latest XBRL company facts

One latest value per concept from companyfacts (163 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 51.72M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
dei EntityPublicFloat Entity Public Float USD 762.66M 2025-06-30 2025 FY 10-K 2026-03-05 0001104659-26-024127
ffd NetFeeAmt NetFeeAmt USD 34,525 2026-05-11 424B5 2026-05-11 0001104659-26-058700
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 250.00M 2026-05-11 424B5 2026-05-11 0001104659-26-058700
ffd TtlFeeAmt TtlFeeAmt USD 34,525 2026-05-11 424B5 2026-05-11 0001104659-26-058700
ffd TtlOfferingAmt TtlOfferingAmt USD 250.00M 2026-05-11 424B5 2026-05-11 0001104659-26-058700
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-11 424B5 2026-05-11 0001104659-26-058700
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-11 424B5 2026-05-11 0001104659-26-058700
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 20.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 630,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -466,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 932.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.88M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.57M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 19.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 4.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap Assets Assets USD 417.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AssetsCurrent Assets, Current USD 416.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 194,000 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 468,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 264.30M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001104659-26-058650
us-gaap Cash Cash USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 113.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 113.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 68.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 40.50M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.31M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001104659-26-058650
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 51.21M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 51.21M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -134.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 38,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 39,000 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 19.50M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 109.27M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 39,000 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 34.28M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.64M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 9.05M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 109.27M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD -1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.82 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.215 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.008 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.049 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 72.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 28.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 35.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -34.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 745,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -48,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 10.75M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001558370-24-015624
us-gaap InvestmentIncomeNet Investment Income, Net USD 8.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14,000 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 14,000 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 14,000 2024-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 42,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001558370-24-015624
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 11,000 2024-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap Liabilities Liabilities USD 23.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 417.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap LiabilitiesCurrent Liabilities, Current USD 27.84M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001104659-26-094902
us-gaap LongTermInvestments Long-term Investments USD 47.68M 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 201.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -11.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -122.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -133.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -133.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -133.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OperatingExpenses Operating Expenses USD 147.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -142.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 14,000 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 256,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 33,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001104659-26-094902
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 302,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 18,000 2025-12-31 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 134,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -480,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -480,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.68M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PaymentsForRent Payments for Rent USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 53,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 204.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 194.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2024-03-31 2024 Q1 10-Q 2024-05-08 0001558370-24-007197
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 23.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap PrepaidInsurance Prepaid Insurance USD 407,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 185.95M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 199.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 44.92M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 1.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 193.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 18.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -133.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 118.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -538.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 300,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 19.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.50M 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 44.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 11.71 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001558370-24-007197
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 270,239 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 21.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 17.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 81.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 19.01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 81.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 19.01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 11.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 23.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap ShortTermInvestments Short-term Investments USD 279.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 393.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.066 2024-01-23 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 141,459 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 304.49M 2024-01-01 2024-03-31 2025 Q3 10-Q 2025-11-10 0001104659-25-108847
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 59.66M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 605,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 40.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001104659-26-024127
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 47.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 492,956 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-03 0001558370-25-001999
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 46.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 47.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001104659-26-124513

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →